Back
Aligos Therapeutics Stock Predictions

Apple's Space Move Could Send This Pre-IPO Stock Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
ALGS
Aligos Therapeutics
Last Price:
$21.49
Seasonality Move:
-24.57%
7 Day Trial
ALL ACCESS PASS
$
7

Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Aligos Therapeutics Stock Forecast
-
Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 40.6% based on the past 4 years of stock performance.
-
Aligos Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Aligos Therapeutics Stock Undervalued?The current Aligos Therapeutics [ALGS] share price is $21.01. The Score for ALGS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Aligos Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 40.6% based on the past 4 years of stock performance.
Aligos Therapeutics Stock Rating
Sell
37
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics overpriced?
-
Aligos Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Aligos Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aligos.com
52-Week Data
52-Week High:
46.80
52-Week Low:
6.76
Prediction Charts
Market Cap:
75.4M
Price in USD:
21.01
Volume:
713.1K
Beta:
2.47
Technical Analysis
SMA50:
32.07
SMA100:
21.66
SMA200:
17.81
52-Wk Change:
23.59%
Stock Predictions
-
Is Aligos Therapeutics stock public?Yes, Aligos Therapeutics is a publicly traded company.
-
What is the Aligos Therapeutics stock quote today?The Aligos Therapeutics stock price is 21.01 USD today.
-
How to buy Aligos Therapeutics stock online?You can buy Aligos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-24 | 32.27 | 30.43 | 33.04 | 30.22 |
Jan-27 | 29.41 | 25.67 | 30.02 | 25.45 |
Jan-28 | 26.01 | 24.76 | 26.84 | 21.65 |
Jan-29 | 24.83 | 23.95 | 26.40 | 23.95 |
Jan-30 | 24.20 | 23.74 | 24.99 | 23.24 |
Jan-31 | 24.35 | 25.80 | 27.61 | 24.10 |
Feb-3 | 23.40 | 22.57 | 25.24 | 22.56 |
Feb-4 | 23.01 | 26.03 | 26.15 | 22.90 |
Feb-5 | 26.00 | 25.32 | 26.70 | 24.70 |
Feb-6 | 25.52 | 27.50 | 28.10 | 25.02 |
Feb-7 | 27.64 | 27.53 | 28.91 | 26.61 |
Feb-10 | 28.18 | 27.70 | 29.54 | 27.44 |
Feb-11 | 27.00 | 26.02 | 27.30 | 25.54 |
Feb-12 | 25.54 | 21.01 | 26.38 | 20.16 |
Aligos Therapeutics Earnings
Aligos Therapeutics Earnings Report: Per Share Aligos Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Aligos Therapeutics Forecast Revenue Growth
Aligos Therapeutics Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.